Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureXiaolin Tian, Guoying Liu, Yeke Wu, Shaohui Wang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease
10.1002/biof.2039 · 2024
Curcumin attenuates copper-induced oxidative stress and neurotoxicity in Drosophila melanogaster
10.1016/j.toxrep.2020.01.015 · 2020
Bioavailability of phytochemicals and its enhancement by drug delivery systems
10.1016/j.canlet.2013.02.032 · 2013
Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria
10.1016/s0009-9236(98)90044-3 · 1998
Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor
10.1002/anie.200800233 · 2008
Blood copper levels and the occurrence of colorectal cancer in Poland
10.3390/biomedicines9111628 · 2021
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors
10.1158/1078-0432.ccr-06-0964 · 2007
Improving on nature: the role of nanomedicine in the development of clinical natural drugs
10.1055/s-0043-102949 · 2017
Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration
10.1073/pnas.1910722117 · 2020
Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation
10.1111/j.1582-4934.2003.tb00198.x · 2003
Black tea polyphenols: A mechanistic treatise
10.1080/10408398.2011.623198 · 2014
Serum copper and zinc levels and the risk of oral cancer: A new insight based on large-scale case-control study
10.1111/odi.12957 · 2019
Copper homeostasis and cuproptosis in health and disease
10.1038/s41392-022-01229-y · 2022
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
10.1038/s41392-024-02071-0 · 2025
Artesunate alleviates Parkinson's disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis
10.1016/j.phrs.2025.107895 · 2025
Resveratrol-like Compounds as SIRT1 Activators
10.3390/ijms232315105 · 2022
Drug delivery systems of natural products in oncology
10.3390/molecules25194560 · 2020
Ultrasound-activated metal-polyphenol nanodroplets for tumor cuproptosis
10.1016/j.biomaterials.2026.124013 · 2026
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects
10.1016/j.ejmech.2024.116355 · 2024
Wilson disease
10.1038/s41572-018-0018-3 · 2018
Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis
10.1038/s41556-021-00822-7 · 2022
Mitochondrial-targeted copper delivery for cuproptosis-based synergistic cancer therapy
2024
Targeting copper in cancer therapy: ‘copper that cancer
10.1039/c5mt00149h · 2015
Targeting cuproptosis in disease treatment: From molecular mechanisms to therapeutic interventions
10.1016/j.preme.2026.100058 · 2026
Ferroptosis: bug or feature?
10.1111/imr.12533 · 2017
Ferroptosis: an iron-dependent form of nonapoptotic cell death
10.1016/j.cell.2012.03.042 · 2012
FDX1 regulates cellular protein lipoylation through direct binding to LIAS
10.1016/j.jbc.2023.105046 · 2023
Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1/ISCA2/ISCU assembly proteins
10.1016/j.freeradbiomed.2023.05.017 · 2023
Inhibitory act of selenoprotein P on Cu(+)/Cu(2+)-induced tau aggregation and neurotoxicity
10.1021/ic501788v · 2014
Special issue: cytotoxicity, antioxidant and anticancer activity of natural products, 2nd edition
10.3390/ijms27041623 · 2026
Orchestrating mitochondrial catastrophe: mechanistic insights and therapeutic frontiers of cuproptosis in precision pharmacology
10.1016/j.coph.2026.102629 · 2026
Apoptosis: a review of programmed cell death
10.1080/01926230701320337 · 2007
Advances in drug delivery systems, challenges and future directions
10.1016/j.heliyon.2023.e17488 · 2023
A safe saponin-based nano-strategy for manganese-mediated STING activation
10.1016/j.jconrel.2025.114303 · 2025
Understanding the prooxidant action of plant polyphenols in the cellular microenvironment of malignant cells: role of copper and therapeutic implications
2022
Discovery of natural resorcylic acid lactones as novel potent copper ionophores covalently targeting prdx1 to induce cuproptosis for triple-negative breast cancer therapy
10.1021/acscentsci.4c02188 · 2025
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy
2024
Copper regulation of hypoxia-inducible factor-1 activity
10.1124/mol.108.051516 · 2009
Mechanisms of copper ion mediated Huntington's disease progression
10.1371/journal.pone.0000334 · 2007
Oral bioavailability comparison of artemisinin, deoxyartemisinin, and 10-deoxoartemisinin based on computer simulations and pharmacokinetics in rats
10.1021/acsomega.0c05465 · 2021
Elesclomol rescues mitochondrial copper deficiency in disease models without triggering cuproptosis
10.1016/j.jpet.2024.100048 · doi-reference
COX17 restricts renal fibrosis development by maintaining mitochondrial copper homeostasis and restoring complex IV activity
10.1038/s41401-023-01098-3 · doi-reference
Oral absorption and bioavailability of tea catechins
10.1055/s-2000-8599 · doi-reference
Identification of tanshinone I as a natural Cu(II) ionophore
10.1016/j.freeradbiomed.2024.11.049 · doi-reference
Complanatoside a disrupts copper homeostasis and induces cuproptosis via directly targeting ATOX1 in prostate cancer
10.1016/j.taap.2025.117257 · doi-reference
Astragaloside IV represses the immune evasion and acidic microenvironment of oral squamous cell carcinoma
10.1186/s11658-026-00869-0 · doi-reference
Tongmai Yangxin Pill ameliorates doxorubicin-induced cardiotoxicity through m6A/ALKBH5/BNIP3 axis
10.1016/j.jep.2026.121213 · doi-reference
Copper/iron bimetal phenolic networks boosted apoptosis/ferroptosis/cuproptosis combined tumor therapy through dual glutathione depletion
10.1016/j.cej.2024.157408 · doi-reference
Targeting ferroptosis and cuproptosis in gastrointestinal cancers: molecular mechanisms, metabolic vulnerabilities, and therapeutic interventions
10.1186/s43556-025-00347-7 · doi-reference
Curcumin is a biologically active copper chelator with antitumor activity
10.1016/j.phymed.2015.11.005 · doi-reference
Necroptosis pathways in tumorigenesis
10.1016/j.semcancer.2022.07.007 · doi-reference
Improved bioavailability and hepatoprotective activity of baicalein via a self-assembled solutol HS15 micelles system
10.2174/1567201820666230606163452 · doi-reference
Nanomedicine strategies for cuproptosis: metabolic reprogramming and tumor immunotherapy
10.1016/j.apsb.2025.07.007 · doi-reference
Ellagic acid and intestinal microflora metabolite urolithin a: a review on its sources, metabolic distribution, health benefits, and biotransformation
10.1080/10408398.2022.2036693 · doi-reference
Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal
10.1016/j.ijpharm.2011.08.023 · doi-reference
Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats
10.1016/j.jep.2012.09.005 · doi-reference
Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives
10.1186/s13045-024-01589-8 · doi-reference
Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review
10.21037/cdt-22-214 · doi-reference
Pyroptosis: mechanisms and diseases
10.1038/s41392-021-00507-5 · doi-reference
Improving the stability and bioavailability of tea polyphenols by encapsulations: a review
10.1016/j.fshw.2021.12.011 · doi-reference
DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis
10.1186/s10020-025-01125-5 · doi-reference
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
10.1038/s41598-017-07452-w · doi-reference
The structural modification of natural products for novel drug discovery
10.1080/17460441.2016.1272757 · doi-reference
Regulation of ferroptotic cancer cell death by GPX4
10.1016/j.cell.2013.12.010 · doi-reference
Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies
10.1038/s41420-023-01796-1 · doi-reference
Copper ionophore complex ES-Cu synergizes with quercetin to target FDX1, promote cuproptosis, and reverse lenvatinib resistance in hepatocellular carcinoma cells
10.1016/j.jare.2025.08.066 · doi-reference
A mitochondrion–targeted natural polyphenolic copper carrier overcomes tumor resistance to cisplatin by potentiating cuproptosis
10.1186/s13046-026-03642-5 · doi-reference
A novel GSH depletor for simultaneous ferroptosis and cuproptosis Activation in hepatocellular carcinoma
10.1016/j.bcp.2025.117488 · doi-reference
Necroptosis and tumor progression
10.1016/j.trecan.2021.09.003 · doi-reference
SRF/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC
10.1016/j.intimp.2025.114165 · doi-reference
Copper metabolism in cell death and autophagy
10.1080/15548627.2023.2200554 · doi-reference
Cuproptosis in stroke: focusing on pathogenesis and treatment
10.3389/fnmol.2024.1349123 · doi-reference
Cuproptosis: mechanisms and links with cancers
10.1186/s12943-023-01732-y · doi-reference
Identification of cuproptosis-related genes in nonalcoholic fatty liver disease
10.1155/2023/9245667 · doi-reference
Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase
10.1073/pnas.040461197 · doi-reference
Improved oral bioavailability of artemisinin through inclusion complexation with beta- and gamma-cyclodextrins
10.1016/s0378-5173(01)00796-7 · doi-reference
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer
10.1096/fj.202300980r · doi-reference
Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis
10.1016/j.cell.2022.06.038 · doi-reference
Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin-induced cardiotoxicity
10.1111/bph.17468 · doi-reference
First establishment of LC-MS/MS method for quantitative analysis of pharmacokinetics and tissue distribution of trilobatin-comparison of three administration modes
10.1002/bmc.70426 · doi-reference